September/October Issue

Cover Stories

Policy / Public Health
ID Specialists Not Immune to Burnout

Inside This Issue

Blogs
Where Has All the Joy Gone?
Policy / Public Health
ID’s Revenue Dropped Below Pre-Pandemic Levels
Covid-19
IDSA Updates COVID-19 Guidelines To Include Pemgarda
Resistance / Stewardship
Low-Income Residents Bearing the Brunt Of Drug-Resistant Candida auris
Bacterial Infections
Meningococcal Cases Increasing in U.S.
Respiratory
Upcoming Respiratory Season Likely to Be Moderate
Immunology / Vaccination
Changes to RSV Vaccine Recommendations Aim to Help Those Most at Risk
Pediatric Infections
Beyfortus—Breakthrough in Pediatric RSV Prevention
HIV/AIDS
HIV Positivity Associated With Lower Risk for Multiple Sclerosis
Resistance / Stewardship
Zerbaxa Appears Effective in Adults With Cystic Fibrosis
Immunocompromised Conditions
New Guidance Available for Processing Cystic Fibrosis Respiratory Tract Samples
HIV/AIDS
One-Fourth of Initial PrEP Prescriptions Not Dispensed
Diagnostic Testing
Diagnostic Digest
Viral Infections
Although Safe, Tecovirimat Did Not Improve Clade I Mpox Resolution in the DRC
Review Articles
Beyond the Bedside: Alternative Streams of Revenue for Infectious Disease Specialists
Antibiotic Answers
Antimicrobial Duos for Infective Endocarditis Caused by Enterococcus Species
ARTclass
New Data Show Lenacapavir’s Efficacy for PrEP
Review Articles
New Strategies to Extend the HIV Treatment Cascade for CVD Prevention
Review Articles
RDTs and RASTs: The Current Landscape